Mechanisms of development of antipsychotic-induced metabolic disorders: pharmacogenetic aspect

Antipsychotics are the main drug group in the treatment of disorders of the schizophrenic spectrum. At the same time, this drug group requires long-term use, has a narrow therapeutic breadth and a large spectrum and high severity of undesirable drug reactions, the manifestation of which is largely d...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	R. F. Nasyrova, M. Yu. Tolmachev, D. A. Sychev, K. K. Yakhin, N. G. Neznanov
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Siberian State Medical University (Tomsk) 2018-01-01
Цуврал:	Бюллетень сибирской медицины
Нөхцлүүд:	pharmacogenetics antipsychotics metabolic disorders weight gain pharmacodynamics factor pharmacokinetic factor
Онлайн хандалт:	https://bulletin.ssmu.ru/jour/article/view/1022
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!